NCT00400946 2026-02-1305-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenDana-Farber Cancer InstitutePhase 3 Completed800 enrolled 22 charts
NCT00928200 2019-02-19Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Terminated1 enrolled 7 charts